[{"id":"e17dace3-40cf-43d5-bbae-779980aa63c9","acronym":"","url":"https://clinicaltrials.gov/study/NCT02938299","created_at":"2022-04-11T23:53:12.156Z","updated_at":"2024-07-02T16:35:10.976Z","phase":"Phase 3","brief_title":"Neoadjuvant L19IL2/L19TNF- Pivotal Study","source_id_and_acronym":"NCT02938299","lead_sponsor":"Philogen S.p.A.","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Nidlegy (darleukin/fibromun) • darleukin (L19IL2)"],"overall_status":"Recruiting","enrollment":" Enrollment 214","initiation":"Initiation: 07/01/2016","start_date":" 07/01/2016","primary_txt":" Primary completion: 10/01/2024","primary_completion_date":" 10/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-04-08"}]